Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K211564
    Date Cleared
    2021-10-19

    (152 days)

    Product Code
    Regulation Number
    870.1650
    Reference & Predicate Devices
    Predicate For
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Sterile High-pressure Angiographic Syringes for Single-use are intended for the injection of contrast media or saline: they shall be used with US legally marketed angiographic injectors.

    Device Description

    The subject devices are identical to all models of predicate devices of K192657. It includes disposable syringes, connection tube, J shape tube and spike. Labeling of subject device now includes pediatrics in the patient population.

    AI/ML Overview

    This document is a 510(k) summary for Sterile High-pressure Angiographic Syringes for Single-use. It primarily focuses on demonstrating substantial equivalence to a predicate device (K192657) and does not contain information about a study proving specific acceptance criteria in the context of device performance metrics like accuracy, sensitivity, or specificity for AI/ML technologies.

    This type of submission typically demonstrates the device meets a set of performance standards or specifications, rather than a "study that proves the device meets the acceptance criteria" in the way a clinical trial or AI performance study would. The acceptance criteria here relate to physical, chemical, and biological properties, as well as compatibility.

    Therefore, many of the requested details, such as sample size for test sets, data provenance, number of experts for ground truth, adjudication methods, MRMC studies, standalone performance studies, and training set details, are not applicable to this type of device submission.

    Here's the available information based on the document:

    1. Table of Acceptance Criteria and Reported Device Performance

    The document lists various non-clinical tests and standards that the device complies with, along with some performance specifications.

    ItemAcceptance Criteria (Standard/Test/Specification)Reported Device Performance
    Product CodeDXTDXT
    Regulation NumberCFR 870.1650CFR 870.1650
    Indications for UseFor injection of contrast media or saline with US legally marketed angiographic injectors.Sterile High-pressure Angiographic Syringes for Single-use are intended for the injection of contrast media or saline; they shall be used with US legally marketed angiographic injectors.
    Mode of operationPower-driven operation, single usePower-driven operation, single use
    SterilityEO SterilizedEO Sterilized
    Single UseYesYes
    Max. Withstanding Pressure (Syringe)300psi, 400psi, 1200psi300psi, 400psi, 1200psi (per specific models, e.g., 100101 at 400psi, 300101 at 1200psi)
    Max. Withstanding Pressure (Connection Tube)300psi, 400psi, 1200psi300psi, 400psi, 1200psi (per specific models)
    Max. Withstanding Pressure (Spike)400 psi400 psi (for specific models)
    Syringe PerformanceISO 7886ISO 7886
    Luer ConnectorISO 594-1; ISO 594-2ISO 594-1; ISO 594-2
    CompatibilityPass (with specific injectors outlined in Tables 1, 2, 3)Pass
    BiocompatibilityNo Cytotoxicity, No Irritation, No Sensitization, No Pyrogen, No Acute Toxicity, No HemolysisNo Cytotoxicity, No Irritation, No Sensitization, No Pyrogen, No Acute Toxicity, No Hemolysis
    Endotoxin Limit20 EU per device20 EU per device
    EO/ECH Residue LimitLimited Contact: ≤ 24h, EO: 0.6mg/day, ECH: 1.28mg/day for 10kg patient (Children) as per ISO 10993-7EO/ECH residual test has been conducted on the models in this submission and test results have demonstrated EO/ECH residue level meet the residue limit for 10kg children group as per ISO 10993-7. (This is a specific test mentioned to justify the change in labeling regarding pediatric use compared to the predicate).
    Sterilization ResidualsISO 10993-7:2008 (AMD1:2019)Complies with standard
    Seal StrengthASTM F88/F88M-15Complies with standard
    Seal Leak DetectionASTM F1929-15Complies with standard
    Bacterial EndotoxinsUSP 41-NF36 2018 <85>Complies with standard
    Sterile Hypodermic Syringes (Manual Use)ISO 7886-1:2017Complies with standard
    Sterile Hypodermic Syringes (Power-driven)ISO 7886-2:1996Complies with standard
    Conical fittings (Luer taper)ISO594-1:1986, ISO594-2:1998Complies with standards
    In Vitro CytotoxicityISO 10993-5:2009Complies with standard (No Cytotoxicity)
    Irritation and Skin SensitizationISO 10993-10:2010Complies with standard (No Irritation, No Sensitization)
    Interactions with BloodISO 10993-4:2017Complies with standard (No Hemolysis)
    Hemolytic PropertiesASTM F756:2017Complies with standard (No Hemolysis)
    Pyrogen TestUSP 41 NF 36<151>Complies with standard (No Pyrogen)
    Sterilization ProcessISO 11135:2014Complies with standard
    Particulate MatterUSP <788>Complies with standard
    Shelf life5 years5 years

    2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)

    • The document does not specify sample sizes for the individual non-clinical tests (e.g., number of syringes tested for pressure, number of samples for biocompatibility).
    • Data provenance: Not explicitly stated, but the submission is from Shenzhen Boon Medical Supply Co., Ltd. in China, suggesting the tests were likely conducted in China. The submission itself is dated August 13, 2021, and received August 23, 2021, implying these are retrospective test results for device validation.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience)

    • This is not applicable. The "ground truth" for this medical device (angiographic syringes) involves meeting engineering specifications and biological safety standards, not diagnostic interpretations that require expert consensus. The compliance is against defined standards (e.g., ISO, ASTM, USP) and internal specifications.

    4. Adjudication method (e.g., 2+1, 3+1, none) for the test set

    • This is not applicable for this type of device. Adjudication methods are typically used in clinical studies for diagnostic accuracy, where disagreements between readers or algorithms need resolution. Here, the tests yield objective pass/fail results against established criteria.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    • This is not applicable. The device is a physical medical instrument (syringe), not an AI/ML diagnostic or assistive tool.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

    • This is not applicable. The device is a physical medical instrument (syringe), not an AI/ML algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

    • The "ground truth" in this context is defined by international and national standards (e.g., ISO 10993, ASTM F88, USP 41) and the device's own engineering specifications (e.g., maximum pressure resistance, volume, material properties). Compliance is measured against these objective criteria.

    8. The sample size for the training set

    • This is not applicable. There is no AI/ML component, therefore no "training set."

    9. How the ground truth for the training set was established

    • This is not applicable. There is no AI/ML component, therefore no "training set" ground truth.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1